Related Experiment Videos
TCNU in colorectal cancer. How many patients are needed to demonstrate that a drug doesn't work?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
l-Lysine Acts as a Serotonin Type 4 Receptor Antagonist to Counteract In Vitro and In Vivo the Stimulatory Effect of Serotonergic Agents on Aldosterone Secretion in Man.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2017
Adjuvant treatment of colon-cancer - a plea for a large-scale European trial.
Oncology reports·2011
Adjuvant treatment of colon cancer: past, present and future.
Journal of chemotherapy (Florence, Italy)·2007
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2006
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced renal-cell carcinoma: randomized open-label phase 3 LITESPARK-012 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC expressing PD-L1 ≥50%: The PERSEE randomized phase III trial (GFPC 01-2020).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFOX6 in high-risk stage III colon cancer: Results of the international IROCAS study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026